跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,042 条关于
“PharmaTher Holdings”
全部
1,042
临床试验
86
药物
64
机构
160
资讯
732
去年
PharmaTher on Track for Ketamine FDA Resubmission, Anticipates Q2 2025 Approval
4年前
PharmaTher Secures U.S. Patent for Advanced Ketamine Production Technology
10个月前
PharmaTher Secures Exclusive Rights to Long-Acting Injectable Ketamine Technology for Treatment-Resistant Depression
2年前
PharmaTher Receives FDA Goal Date of October 29, 2024 for Priority Ketamine ANDA Approval
上个月
PharmaTher Partners with KetaMist Inventor to Pursue FDA Approval for Needle-Free Ketamine Platform in Treatment-Resistant Depression
6个月前
PharmaTher Advances Microneedle Patch Platform for Therapeutic Peptides with PatchPrint Manufacturing System
2年前
PharmaTher Sets August 2025 FDA Approval Goal Date for Ketamine Product, Confirms Full Funding Through Commercial Launch
去年
FDA Issues Second Complete Response Letter for PharmaTher's Ketamine ANDA
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
European Commission Approves Novo Holdings' $16.5B Catalent Acquisition
第 1 页,共 74 页
上一页
下一页